Boehringer Ingelheim Thailand Honored As Top Employer For The Fifth Consecutive Year
- Boehringer Ingelheim is one of 15 global Top Employers worldwide
- Achieved Global Recognition and Top Employer Certification in 29 countries From Top Employers Institute®
- Outstanding employer benefits with emphasis on wellbeing, attractive work environment, and rewards and recognition
BANGKOK, Jan. 18, 2023 /PRNewswire/ -- Boehringer Ingelheim has been awarded for the third year in succession a "Global Top Employer" by the Top Employers Institute, one of the world's 15 best employers. Regionally, it has been recognized as a Top Employer across ASEAN, Korea, Australia, and New Zealand (ASKAN).
The certification highlights the company's commitment to prioritizing mental health for employees, in addition to nurturing talents to instil a changemaker mindset.
Boehringer Ingelheim's employer offerings do particularly stand out in the dimensions of wellbeing, work environment, as well as rewards and recognition. The results reflect the company's holistic employee healthcare and wellbeing approach that, beyond its emphasis on mental health, integrates concepts of physical, social and financial health. Through dedicated programs and offers, its employees receive support that is relevant for them and their families. This includes a work environment of physical and emotional security, an inclusive way of working together creating a sense of belonging, mental health awareness initiatives and manager trainings, focus on work-life-balance, opportunities for volunteering, and competitive pay and benefits.
In Thailand, Boehringer Ingelheim has won the award for five years running and this year has been certified among the top three employers in the local market. Our focus on employee well-being, engagement and our "Sustainable Development - For Generations" framework includes key initiatives such as volunteering and donating around 200,000 THB to the Handicapped Animal Foundation, supporting 124 children in Children's Village School Moo Baan Dek in Kanchanaburi province to have better opportunities to develop their health and education, and planting 120 mangrove trees and cleaning up 64.5 Kilograms of marine waste at the Bangpu Nature Education Center in Samut Prakan province.
"Being certified by the Top Employer Institute means a lot to us. This certification reflects our commitment towards our employees' well-being, development, and growth. I believe that empowering our teams and continuing to invest in a culture of diversity and inclusion, fostering innovation through cross-functional collaboration allows us to deliver our purpose of transforming lives through generations in Thailand, " said Rodrigo Lau, General Manager / Head of Human Pharma, Boehringer Ingelheim Thailand.
Nurturing talent and instilling a growth mindset is driven throughout the organisations' key employee programmes with the aim to support broader skill sets development and create a fulfilling work environment. Some of these programmes include the Regional Talent Move programme which aims to build agility and resilience by allowing employees to take on a stretch assignment in a different country for up to six months to work on a project or business problem, and the B-effect project that is run in partnership with Ashoka, an international network focused on social entrepreneurship and teaches employees to create positive change and innovation by developing a change maker mindset using a six step process.
"We constantly challenge ourselves to raise the bar of our people's well-being and consistently invest in developing their skills and the value they can bring to the organisation and society. By doing so, our people are equipped with leadership and entrepreneurial skills to improve outcomes for patients and animals," said David Serés, Human Resources Director, ASKAN, Boehringer Ingelheim.
Boehringer Ingelheim has stepped up its commitment towards sustainability within Asia Pacific by launching initiatives such as Making More Health that enable employees to reach their full potential and impact on health and societal challenges. While partnering with the Global Alliance for Rabies Control (GARC), many employees have participated in animal vaccination campaigns to help control and prevent the spread of rabies in the region, making an impact on animal health. In addition, employees' general well being and growth mindset are nurtured through a variety of learning and training experiences, regular team discussions, employee assistance and stress relief programs, family days and disease awareness talks.
Boehringer Ingelheim has been listed among the top employers in multiple countries and regions for the past nine years. This year, Boehringer Ingelheim will receive the award in 29 countries, as well as additional certifications in Europe, the Asia Pacific, and – ranked first – the Latin America regions.
About Boehringer Ingelheim
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at https://www.boehringer-ingelheim.com/
About Top Employers Institute
Top Employers Institute is the global authority on recognising excellence in People Practices. We help accelerate these practices to enrich the world of work. Through the Top Employers Institute Certification Programme, participating companies can be validated, certified, and recognised as an employer of choice. Established over 30 years ago, Top Employers Institute has certified 2 052 organisations in 121 countries/regions. These certified Top Employers positively impact the lives of over 9.5 million employees globally.
Top Employers Institute. For a better world of work.
MLR Code: NP-TH-100114
SOURCE Boehringer Ingelheim
Upcoming Life Sciences Events
- March 2023
- Basel: BIO-Europe Spring® 2023
- Zurich: Swiss Nordic Bio 2023
- April 2023
- Basel: Swiss Biotech Day 2023
Latest company news
GHIT Fund Announces New Investments: A Total of Approximately 260 Million Yen in Shionogi, Takeda Pharmaceutical for New Malaria Drug Development
Publication of exemption document in relation to the proposed combination of Chr. Hansen and Novozymes, confirmation of outlook for 2022/23 and proposed candidates to the Board of Directors of the combined company